MRUS vs. APLT

Last updated Apr 1, 2026

Compare and contrast key facts about Merus N.V. (MRUS) and Applied Therapeutics, Inc. (APLT).

Performance

MRUS vs. APLT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merus N.V. (MRUS) and Applied Therapeutics, Inc. (APLT). The values are adjusted to include any dividend payments, if applicable.

MRUS vs. APLT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
MRUS Merus N.V.	0.00%	114.03%	52.91%	77.76%	-51.35%	81.40%	24.50%	1.37%
APLT Applied Therapeutics, Inc.	3.00%	-88.32%	-74.44%	340.79%	-91.51%	-59.34%	-19.32%	190.21%

Fundamentals

Market Cap MRUS : $6.81B APLT : $14.99M
EPS MRUS : -$4.56 APLT : -$0.12
PS Ratio MRUS : 129.06 APLT : 14.97
Total Revenue (TTM) MRUS : $51.17M APLT : $1.00M
Gross Profit (TTM) MRUS : -$111.30M APLT : -$28.46M
EBITDA (TTM) MRUS : -$323.66M APLT : -$100.52M

Returns By Period

MRUS

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

APLT

• 1D: 0.00%
• 1M: 0.00%
• YTD: 3.00%
• 6M: -82.97%
• 1Y: -78.93%
• 3Y*: -49.74%
• 5Y*: -64.48%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

MRUS vs. APLT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

APLT

APLT Risk / Return Rank: 24
APLT Sharpe Ratio Rank: 23
APLT Sortino Ratio Rank: 36
APLT Omega Ratio Rank: 38
APLT Calmar Ratio Rank: 9
APLT Martin Ratio Rank: 13

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRUS vs. APLT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Merus N.V. (MRUS) and Applied Therapeutics, Inc. (APLT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	MRUS	APLT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.41	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.49	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.39	—

Correlation

The correlation between MRUS and APLT is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

MRUS vs. APLT - Dividend Comparison

Neither MRUS nor APLT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	MRUS	APLT	Difference
Max Drawdown Largest peak-to-trough decline	—	-99.83%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-93.71%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-99.63%	—
Current Drawdown Current decline from peak	—	-99.81%	—
Average Drawdown Average peak-to-trough decline	—	-75.56%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	59.08%	—

Volatility

Volatility by Period

	MRUS	APLT	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	0.00%	—
Volatility (6M) Calculated over the trailing 6-month period	—	188.73%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	191.88%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	133.53%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	123.88%	—

Financials